去热原灭菌管瓶市场规模、份额和成长分析（按产品类型、最终用户和地区）- 产业预测 2025-2032

2023 年去热原无菌管瓶市场规模价值 39 亿美元，预计将从 2024 年的 41.3 亿美元成长到 2032 年的 65.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.9%。

由于製药和生技领域对无菌包装的需求不断增加，全球去热原无菌管瓶市场正在显着成长。这些管瓶设计为不含有害热原，随着药物开发和疫苗生产的增加，它们对于确保医疗产品的安全性和完整性至关重要。製造商正注重品质合规性和技术创新，以最大限度地降低污染风险。此外，医疗保健产业的扩张推动了市场的持续成长，凸显了安全药品储存和运送的重要性。对永续性的日益关注也影响着市场，製造商正在寻求环保包装解决方案和更节能的生产方法，以减少碳排放，同时保持产品完整性。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

去热原无菌管瓶市场规模（依产品类型及复合年增长率） (2025-2032)

• 市场概况
• 少于 5 毫升
• 5mL～20ml
• 20mL

去热原无菌管瓶市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 临床实验室
• 混合实验室
• 製药和生物技术公司

去热原无菌管瓶市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Schott AG（Germany）
• Gerresheimer AG（Germany）
• Stevanato Group（Italy）
• SGD Pharma（France）
• Nipro Corporation（Japan）
• West Pharmaceutical Services, Inc.（USA）
• Corning Incorporated（USA）
• DWK Life Sciences GmbH（Germany）
• Thermo Fisher Scientific Inc.（USA）
• SiO2 Materials Science（USA）
• Ompi（Italy）
• Piramal Glass（India）
• Stoelzle Glass Group（Austria）
• Amcor plc（Australia）
• AptarGroup, Inc.（USA）
• Bormioli Pharma（Italy）
• Daikyo Seiko, Ltd.（Japan）
• Vetter Pharma International GmbH（Germany）
• Adelphi Healthcare Packaging（UK）
• Pacific Vial Manufacturing Inc.（USA）

结论和建议

Depyrogenated Sterile Empty Vials Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.13 billion in 2024 to USD 6.53 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The global market for depyrogenated sterile empty vials is experiencing significant growth, driven by the escalating demand for aseptic packaging in the pharmaceutical and biotech sectors. These vials, designed to be free of harmful pyrogens, are essential for ensuring the safety and integrity of medical products amid increasing drug development and vaccine production. Manufacturers are focusing on quality compliance and technological innovations to minimize contamination risks. Additionally, the healthcare industry's expansion is priming the market for sustained growth, underscoring the importance of secure drug storage and delivery. A rising emphasis on sustainability is also shaping the market, with manufacturers exploring eco-friendly packaging solutions and energy-efficient production practices to reduce their carbon footprint while maintaining product integrity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Depyrogenated Sterile Empty Vials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Depyrogenated Sterile Empty Vials Market Segments Analysis

Global Depyrogenated Sterile Empty Vials Market is segmented by Product Type, End User and region. Based on Product Type, the market is segmented into < 5 mL, 5 mL - 20ml and > 20 mL. Based on End User, the market is segmented into Clinical Labs, Compounding Labs and Pharma and Biotech Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Depyrogenated Sterile Empty Vials Market

The expansion of the pharmaceutical sector significantly fuels the need for depyrogenated sterile empty vials, which are essential for the packaging of injectable medications, vaccines, and other parenteral formulations. With the continuous growth and aging of the global population, there is an anticipated rise in the demand for pharmaceutical products, consequently elevating the need for corresponding packaging solutions. This trend underlines the vital role that depyrogenated sterile empty vials play in ensuring the safe and effective delivery of medical treatments, positioning them as a crucial element in the supply chain of the pharmaceutical industry.

Restraints in the Depyrogenated Sterile Empty Vials Market

The market for depyrogenated sterile empty vials faces certain challenges that could hinder its growth prospects. The intricate processes and rigorous quality control measures required for their production often lead to elevated manufacturing costs. Furthermore, the highly competitive landscape of the pharmaceutical sector can create significant pricing pressures, compelling manufacturers to lower their prices. This combination of increased production expenses and reduced profitability may pose substantial restraints on the overall growth of the depyrogenated sterile empty vials market, as manufacturers navigate the complexities of maintaining quality while remaining financially viable in a crowded marketplace.

Market Trends of the Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials market is experiencing significant growth, largely fueled by the expanding pharmaceutical industry. As research and development in pharmaceuticals intensify, there is a rising demand for packaging solutions that ensure drug safety and efficacy, particularly for injectables. This trend is further propelled by the increasing production of biologics, vaccines, and specialized medications, all of which necessitate stringent sterility standards in packaging. As businesses strive to meet regulatory compliance and consumer safety expectations, the market for these vials is positioned for continued expansion, reflecting a robust alignment with industry needs for advanced sterile packaging solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Depyrogenated Sterile Empty Vials Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• < 5 mL
• 5 mL - 20ml
• 20 mL

Global Depyrogenated Sterile Empty Vials Market Size by End User & CAGR (2025-2032)

• Market Overview
• Clinical Labs
• Compounding Labs
• Pharma and Biotech Companies

Global Depyrogenated Sterile Empty Vials Market Size & CAGR (2025-2032)

• North America (Product Type, End User)
  • US
  • Canada
• Europe (Product Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DWK Life Sciences GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SiO2 Materials Science (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ompi (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stoelzle Glass Group (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daikyo Seiko, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adelphi Healthcare Packaging (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Vial Manufacturing Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations